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Summary
Chromatin dynamics that regulate Ifng gene expres-
sion are incompletely understood. By using cross-
species comparative sequence analyses, we have
identified conserved noncoding sequences (CNSs)
upstream of the Ifng gene, one of which, located 222
kb from the transcriptional start site, contains clus-
tered consensus binding sequences of transcription
factors that function in T cell differentiation. CNS222
was uniquely associated with histone modifications
typical of accessible chromatin in both T helper 1
(Th1) and Th2 cells and demonstrated significant and
selective T-bet (T-box transcription factor expressed
in T cells, Tbx21)-dependent binding and enhancer
activity in Th1 cells. Deletion of CNS222 in the context
of an Ifng reporter transgene ablated T cell receptor-
dependent and -independent Ifng expression in Th1 ef-
fectors and similarly blocked expression by cytotoxic
T lymphocytes and natural killer cells. Thus, a single
distal element may be essential for Ifng gene expres-
sion by both innate and adaptive immune effector
cell lineages.
Introduction
The pathogen-induced differentiation of effector CD4+
T cells from antigen-naive precurors is a fundamental
property of adaptive immunity. T helper 1 (Th1), Th2,
and Th17 effector T cells are distinguished on the basis
of differential expression of cytokines that are produced
upon antigen rechallenge. Th1 cells produce interferon g
(IFNg) and eradicate intracellular bacteria, viruses, and
protozoa, whereas Th2 cells produce interleukins 4, 5,
and 13 (IL-4, IL-5, and IL-13) and eliminate extracellular
parasites (Mosmann and Coffman, 1989; Murphy and
Reiner, 2002). Th17 cells produce IL-17A and IL-17F
and may have evolved to eradicate extracellular bacteria
*Correspondence: rdzialo@path.uab.edu(McKenzie et al., 2006; Weaver et al., 2006). Th1 devel-
opment is driven by the sequential actions of IFNg and
IL-12, signaling through signal transducer and activator
of transcription 1 and 4 (STAT1 and STAT4), respec-
tively. Coordinate signaling through the TCR and STAT1
in naive CD4+ T cells induces the expression of the Th1-
specific transcription factor, T-bet, which induces ex-
pression of the Il12rb2 gene, thereby conferring IL-12
responsiveness through STAT4 (Kaplan et al., 1996;
Murphy and Reiner, 2002; Szabo et al., 2000; Thierfelder
et al., 1996). T-bet also appears to direct chromatin re-
modeling at the Ifng locus in developing Th1 cells, while
interfering with the differentiation of Th2 cells (Ansel
et al., 2003; Mostoslavsky et al., 2003; Mullen et al.,
2001). Th2 development is initiated via IL-4-dependent
STAT6 signaling and the induction of the transcription
factor GATA-3 (Zheng and Flavell, 1997). Upregulation
of GATA3 activates the linked Il4, Il13, and Il5 gene clus-
ter, or Th2 cytokine locus, by initiating remodeling of
local chromatin and by acting as acute transcription
factor, while also silencing the Ifng gene (Ansel et al.,
2006). Th17 development is induced via sequential
actions of TGF-b plus IL-6 and IL-23, although detailed
signaling pathways are currently lacking (Weaver et al.,
2006).
Th1 and Th2 cells display distinct, heritable, and sta-
ble alterations at lineage-specific cytokine loci that are
responsible for the rapid and efficient production of
effector cytokines in recall responses. The epigenetic
modifications that alter chromatin structure and result
in Th1- or Th2-specific gene expression include changes
to the position, composition, and conformation of the
nucleosome, modifications of histones, as well as mod-
ifications to the DNA itself (Ansel et al., 2003, 2006; Lee
et al., 2006; Mostoslavsky et al., 2003; Smale and Fisher,
2002). The Th2 cytokine locus has been extensively
studied and has emerged as a model for understanding
chromatin dynamics during T cell differentiation (Ansel
et al., 2006). In Th2 cells, DNase I hypersensitivity sites
have been identified in the Il4 promoter, in the intergenic
region between the Il4 and Il13 genes and in the second
intron of the Il4 gene (Agarwal and Rao, 1998; Henkel
et al., 1992; Takemoto et al., 1998). Many of these sites
are not accessible in Th1 cells, reflecting differential
chromatin remodeling in Th1 and Th2 cells. Demethyla-
tion of CpGs has also been associated with Th2 differen-
tiation at multiple sites in the Th2 locus, including sites in
introns 1 and 2 of the Il4 gene, at sites 30 of the Il4 gene,
and at sites in the Il4-Il13 intergenic region (Agarwal and
Rao, 1998; Bird et al., 1998; Guo et al., 2002; Henkel
et al., 1992; Lee et al., 2002; Santangelo et al., 2002;
Takemoto et al., 1998). Similarly, histone hyperacetyla-
tion has been demonstrated in Th2 cells at the promoter
of both the Il4 and Il13 genes and in regions 30 of the Il4
gene that map to DNase I hypersensitivity sites (Ansel
et al., 2006). The preferential expression of the Il4, Il13,
and Il5 genes from a single allele suggests that long-
range alterations in chromatin structure at this locus
are likely to contribute to their coordinate regulation
(Kelly and Locksley, 2000).
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quences that regulate gene expression has been facili-
tated by advances in bioinformatics-based analyses
(Gu and Su, 2005; Ptacek and Sell, 2005). Via cross-spe-
cies sequence comparisons, a conserved noncoding
sequence (CNS) was identified between the IL4 and
IL13 genes (CNS1), which, when deleted from a human
yeast artificial chromosome (YAC) transgene, reduced
expression of all genes in the Th2 cytokine cluster (Loots
et al., 2000). Targeted deletion of CNS1 from the endog-
enous mouse loci also resulted in diminished expression
of Il4, Il5, and Il13, suggesting that the entire locus is reg-
ulated by a common cis-regulatory element (Mohrs
et al., 2001). Additionally, a locus control region (LCR)
that affects expression of the Il4 and Il13 genes has
been identified in the Rad50 gene, between the Il13
and Il5 genes. Deletion of a conserved DNA element
containing a DNaseI hypersensitivity site in this LCR re-
sulted in reduced Th2 cytokine expression in vitro and
impaired Th2-type responses in vivo (Lee et al., 2005).
The region containing this LCR also appears to be in-
volved in interchromosomal interactions with the Ifng
gene, suggesting that it may play a role in coordinating
both Th1- and Th2-specific cytokine expression (Spilia-
nakis et al., 2005). Deletion of a CNS 30 of the IL-4 gene
resulted in Th2 skewing in vitro and Th1 cells that pro-
duced both IFNg and IL-4, indicative of an element
that contains negative regulatory function (Ansel et al.,
2004).
While there have been substantial advances in the de-
lineation of epigenetic modifications that regulate the
Th2 cytokine locus, less is known about the Ifng locus.
Demethylation of DNA and histone hyperacetylation in
the proximal promoter of the Ifng gene have been ob-
served in Th1 cells but not Th2 cells (Avni et al., 2002;
Fields et al., 2002; Mullen et al., 2002; Young et al.,
1994), and Th1-specific DNase I hypersensitivity sites
have been identified in the Ifng promoter and in introns
1 and 3 (Agarwal and Rao, 1998; Lee et al., 2004; Shnyr-
eva et al., 2004). Transgenic studies have established
that distal cis-regulatory elements are required for line-
age-specific expression of Ifng in Th1 cells and cytotoxic
T lymphocytes (CTLs) (Soutto et al., 2002; Zhu et al.,
2001), and analyses of histone hyperacetylation have
mapped several distal domains that are modified in a lin-
eage- and transcription factor-dependent fashion (Avni
et al., 2002; Fields et al., 2002; Mullen et al., 2002; Soutto
et al., 2002; Young et al., 1994; Zhu et al., 2001), although
none of these sites were functionally characterized. Two
recent studies have identified CNS elements in the Ifng
locus that function in vitro as enhancers for Ifng expres-
sion (Agarwal and Rao, 1998; Lee et al., 2004; Shnyreva
et al., 2004). Lee et al. reported the identification of
a CNS 5 kb upstream of the transcription start site that
enhanced human IFNG gene expression in response to
T-bet and NFAT (Lee et al., 2004). Wilson and coworkers
independently identified this element, which they termed
IFNgCNS1, as well as a second site, called IFNgCNS2,
that is located 17 kb downstream of the transcriptional
start site and also had enhancer function in vitro (Shnyr-
eva et al., 2004). Collectively, these studies provide
strong evidence supporting a role for distal cis-regula-
tory elements in Ifng gene regulation, although in vivo
analyses have been lacking.By using cross-species sequence analyses, we have
identified three conserved noncoding sequences up-
stream of the Ifng transcriptional start site, one of which
(CNS222) contains a cluster of consensus binding se-
quences for transcription factors known to function in
T cell development and differentiation. Promoter-re-
porter assays that coupled this element to the proximal
Ifng promoter demonstrated substantially enhanced T-
bet-dependent expression. Chromatin immunoprecipi-
tation (ChIP) analyses determined that CNS222 inter-
acts with T-bet in Th1 cells and that it resides in an
area of permissive chromatin in both Th1 and Th2 cells,
suggesting that it may play roles in both activating and
silencing expression of Ifng in distinct effector T cell lin-
eages. To investigate the regulatory properties of this
CNS element in vivo, we have developed a bacteria
artificial chromosome (BAC)-based transgenic reporter
system to report Ifng gene expression. Because this ap-
proach reports activation of the transgenic allele without
perturbing endogenous alleles, potential confounding
effects of altered IFNg production were avoided. The
Ifng-Thy1.1 BAC-In transgene faithfully mirrored endog-
enous Ifng gene expression, and conditional deletion of
the CNS222 element resulted in nearly complete loss of
Thy1.1 expression in Th1 cells, CD8+ T cells, and NK
cells, irrespective of activation through the TCR-depen-
dent or TCR-independent pathways. Thus, CNS222
appears to be critically involved in Ifng gene expression,
irrespective of adaptive or innate immune cell lineage.
Results
Identification of a Cluster of Transcription
Factor Consensus Binding Sequences
Upstream of the Ifng Gene
To identify conserved noncoding sequence elements
that might regulate Ifng gene expression, we used the
web-based global alignment tool VISTA (Frazer et al.,
2004) to compare approximately 150,000 kb of DNA
sequence encompassing the Ifng locus from multiple
species. Cross-species sequence comparison of hu-
man, mouse, rat, cow, opossum, and chicken revealed
that while the coding sequence of the Ifng gene is rather
weakly conserved, a number of noncoding sequences
that meet the criteria of a conserved noncoding se-
quence (CNS; greater than 70% sequence identity and
greater than 100 bp long) (Dermitzakis et al., 2005) exist
upstream and downstream of the Ifng gene (Figure 1A
and data not shown). Two of the CNSs, one at 5 kb up-
stream and the other at 17 kb downstream of the Ifng
transcriptional start site, designated CNS1 (or CNS25)
and CNS2 (or CNS+17), respectively, have been de-
scribed previously (Lee et al., 2004; Shnyreva et al.,
2004). Three additional CNSs at 222 kb, 234 kb, and
255 kb relative to the transcriptional start of the mouse
Ifng gene are highly conserved and were chosen for fur-
ther study (Figure 1A). Each of the CNSs was analyzed
for the presence of consensus transcription factor bind-
ing sites (Cartharius et al., 2005) and, while sites were
identified in all of the noncoding sequence elements
tested, an unusually high concentration of consensus
sequences for transcription factors known to be in-
volved in T cell development and cytokine gene expres-
sion was found in CNS222 (Figure 1B). Most striking
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(A) VISTA plot analyses identify conserved noncoding sequences in the Ifng locus. Human sequence is shown on the x axis and percentage sim-
ilarity to mouse, rat, chicken, opossum, and cow on the y axis (Frazer et al., 2004). A schematic representation of the human IFNG locus with 50
and 30 UTRs shaded turquoise, exons in blue, and the horizontal arrow indicating direction of transcription denotes position of the Ifng gene. Red
peaks identify conserved noncoding sequences defined as longer than 100 bp and having greater than 70% sequence identity. Previously iden-
tified CNS1 (CNS25) and CNS2 (CNS+17) are indicated, as are CNSs at 222, 234, and 255 kb, denoting their location in the mouse genome
relative to the transcriptional start of the Ifng gene.
(B) CNS222 DNA sequence alignment. Clustal W was used to perform a multiple alignment of DNA aligning to the CNS222 from multiple species.
MatInspector identified consensus transcription factor binding sites for denoted transcription factor families (Cartharius et al., 2005). Gray boxes
identify highly conserved sequences in which consensus transcription factor binding site hits are identified. The individual consensus sequence
motifs are indicated by black brackets.was the overlapping cluster of STAT, GATA, Ikaros,
and T-box factor consensus binding sequences. Addi-
tionally, although the degree of conservation of the
CNS222 is lower in the opossum and appears to be neg-
ligible in the chicken, transcription factor binding site
analyses showed that a highly similar combination of
transcription factor binding sites is maintained in this
region, even in divergent species (data not shown). Spe-
cifically, highly conserved T-box and nuclear factor ofkappa light chain enhancer in B cells (NF-kB) sites
were located in the genomic region corresponding to
CNS222 in the chicken and opossum, and these sites
were positioned at nearly the same interval (91 base
pairs apart) as in the other mammalian species studied
(96–98 base pairs apart). Thus, while three highly con-
served noncoding sequences containing numerous
transcription factor binding sites were identified up-
stream of the Ifng gene, the dense cluster of sites in
Immunity
720Figure 2. Differential CNS Enhancement of Ifng Promoter Activity by T-bet
Differing lengths of the mouse promoter (gray boxes) were linked to a firefly luciferase reporter. The promoter constructs alone or constructs
containing CNS222, CNS234, or CNS255 (A) or CNS222 containing mutations to the T-box consensus sequence juxtaposed upstream of
the promoter fragments (B) were cotransfected with a renilla luciferase vector to control for transfection efficiency into EL-4 cells with or without
T-bet. Transfected cells were rested for 16 hr, restimulated with PMA and ionomycin for 4 hr, followed by assessment of luciferase expression.
White boxes indicate T-bet responsive units (TRU), orange boxes indicate consensus T-box binding sites, and the hatched gray boxes indicate
a pair of dimeric Brachyury cis elements (TDB). Data are relative light units 6 SEM normalized for renilla luciferase expression and are from at
least three independent experiments.CNS222 along with its high degree of sequence conser-
vation were remarkable and suggested a regulatory role
in IFNg expression.
Enhancer Properties of Distal CNS Elements
in the Ifng Locus
Distal regulatory elements can function as enhancers, si-
lencers, insulators, and locus control regions (West and
Fraser, 2005). To investigate the function of CNS222,
CNS234, and CNS255, a promoter-reporter strategy
for assaying each CNS element coupled with increas-
ingly long fragments of the proximal promoter of Ifng
gene was designed. Nonconserved sequences 8 kb
and 28 kb upstream and 6.5 kb downstream of Ifng
were included in the promoter-reporter assay for com-
parison. In a previous study (Cho et al., 2003), it was
found that a 2 kb fragment of the mouse Ifngpromoter di-
rected expression of a luciferase reporter in activated
EL-4 cells and that luciferase expression was greatly
augmented by the cotransfection of T-bet. Mutation of
Brachyury (Tbx5) consensus sites decreased reporter
expression in the presence of T-bet, thereby identifying
a number of TRU (T-bet responsive units) in the Ifngprox-
imal promoter (a conserved region extendingw2 kb up-stream of the transcriptional start site). When each of
the CNSs was placed upstream of the259 minimal pro-
moter, no enhancement of reporter activity was detected
in either the presence or absence of T-bet cotransfection
(Figure 2). A 468 bp promoter fragment containing one
TRU element increased luciferase expression over the
minimal promoter when cotransfected with T-bet. With
the inclusion of CNS222, luciferase production driven
by the2486 promoter fragment was markedly increased
in the presence of T-bet, while the addition of CNS234
had little effect on reporter expression, irrespective of
T-bet availability. The 22363 promoter fragment con-
taining two TRU elements and a pair of dimeric Bra-
chyury cis elements (TDB) exhibited a similar pattern of
expression in that inclusion of CNS222 significantly in-
creased T-bet-dependent reporter expression over the
proximal promoter fragment alone. Mutations of the con-
sensus T-box site in CNS222 resulted in nearly complete
loss reporter activity compared to the intact element, in-
dicating that T-bet binding to CNS222 is important for
its enhancer activity (Figure 2B and see Figure S1 in the
Supplemental Data available online). CNS234 contains
a weak Brachyury consensus site, and when added to
the22363 promoter fragments and to a 586 bp promoter
A Distal CNS Controls Ifng Gene Expression
721Figure 3. Histone Acetylation and T-bet Binding to CNS and Non-CNS Elements in the Ifng Locus
Naive CD4 T cells were isolated from DO11.10 mice and either assayed directly by ChIP or grown under Th1 or Th2 polarizing conditions. After 5
days of culture, ChIP was performed with either an acetylated H4 (A) or T-bet (B) antibody in resting Th1 and Th2 cells (light colored bars) or in
cells restimulated for 4 hr with PMA and ionomycin (dark bars). Real-time PCR was performed on immunoprecipitated reactions to detect regions
corresponding to the Ifng promoter (IfngP), CNS1, CNS2, the222 kb,234 kb, and CNS255, and nonconserved sequences at28,228, and +6.5
kb denoted by arrows on the VISTA plot of the Ifng locus (A and B). Real-time PCR was also used to detect the HS VA in the Il4 locus from anti-H4
immunprecipitations (C). PCR reactions from anti-H4 immunoprecipitations were normalized to 16S ribosomal promoter from the same prepa-
rations, and the anti-T-bet samples were normalized to input DNA. Identical preparations of the NIH 3T3 fibroblast cell line were analyzed by ChIP
for comparison, and all values are expressed as n-fold increase relative to the fibroblast controls. The relative histone H4 acetylation and T-bet
binding values were calculated with the DDCt method with the normalized 3T3 Cts compared to the normalized T cell Cts. An asterisk (*) denotes
p% 0.001 comparing the acetylation status in Th1 versus Th2 cells (and in Th2 versus Th1 cells in the case of HS VA) at the identified regions.
# identifies regions where acute stimulation in Th1 cells significantly increases (p < 0.05) histone acetylation compared to resting Th1 cells. Data
are given as mean 6 SEM.fragment (Figure S1), this element also enhanced re-
porter expression of these constructs in the presence
of T-bet, albeit to a lesser extent than CNS222. Inclusion
of CNS255, CNS25, CNS+17, and nonconserved (NC)
sequences NC28, NC228, and NC+6.5 (Figure 2A; Fig-
ure S1) had no detectable effect on luciferase reporter
expression in this assay. Thus, CNS222 and CNS234
have T-bet-dependent, enhancer-like properties in vitro,
although with different efficiencies and in distinct con-
texts.
Mapping of Histone Modifications in Upstream
CNS Elements
Changes in the levels of histone acetylation and methyl-
ation are associated with chromatin remodeling and
transcriptional activity. To determine whether CNS222,
CNS234, or CNS255 reside in areas of active chromatin
in naive and effector T cells, we assessed the histoneacetylation and methylation status of these regions in T
cells by using antiacetylated H4- or antidi/trimethylated
H3-specific chromatin immunoprecipitation (ChIP) cou-
pled with quantitative real-time PCR (Figure 3; Figure S2).
We included analyses of the Ifng-proximal promoter
(IfngP), CNS25, CNS+17, and regions that are not asso-
ciated with a conserved noncoding sequence at 28 kb,
228 kb, and +6.5 kb, thereby spanning approximately
75 kb of sequence surrounding the Ifng gene. The 30
Il4 enhancer (HS VA) region was included as a control
for Th2-specific hyperacetylation (Figure 3C). In naive
CD4+ T cells, low amounts of histone acetylation were
detected at all sites examined in the Ifng locus compared
to fibroblast controls (Figure 3A). Interestingly, the
CNS222 demonstrated approximately twice the acety-
lated H4 in naive CD4+ T cells compared to the other sites
examined. Increased acetylation of the IfngP and CNS2
34 was observed in unstimulated Th1 cells compared to
Immunity
722naive cells. When Th1 cells were stimulated for 4 hr, the
acetylation status was unchanged at the IfngP and at
CNS234, while CNS1, CNS255, CNS222, CNS+17,
and the 228 kb, 28 kb, and +6.5 kb regions showed
increased acetylation, with the increases at CNS222,
CNS255, CNS1, and the nonconserved 28 kb region
achieving statistical significance (p < 0.001). The region
at 228 kb had the highest level of hyperacetylation in
both resting and stimulated Th1 cells, although the fold
increase compared to acute stimulation was less than
that for CNS1 and CNS222 (4.8- versus 7.0- and 6.4-
fold, respectively). Similarly, the 228 kb region had the
greatest degree of H3 di/trimethylation in activated Th1
cells (Figure S2). It appears, therefore, that while there
are clear trends toward correlation between sites of in-
terspecies sequence conservation and histone modi-
fication in the Ifng locus, these correlations are not
absolute (Chang and Aune, 2005).
Compared to naive and Th1 cells, rested and restimu-
lated Th2 cells demonstrated hyperacetylation at the
IL-4 VA enhancer region (Figure 3C), as expected (Avni
et al., 2002). Surprisingly, however, in contrast to each
of the other sites examined, at which both unstimulated
and stimulated Th2 cells were reproducibly diminished
(compared to the histone modification observed in
both Th1 and naive cells), Th2 cells showed elevated
acetylation and methylation at CNS222 relative to fibro-
blast controls. Indeed, unstimulated Th2 cells con-
sistently demonstrated enhanced acetylation and
methylation of CNS222 that was comparable to both
unstimulated Th1 cells and naive cells (Figure 3A; Fig-
ure S2). Collectively, these data suggested that histones
associated with the Ifng locus in naive T cells are already
modified to a level comparable to unstimulated Th1
cells. Th2 development was associated with diminished
histone acetylation, and presumably accessibility, at all
sites except CNS222, which was comparable to both
naive and unstimulated Th1 cells. Finally, in corrobora-
tion with Chang and Aune (2005), there was differential
modification of histones in CNSs (e.g., CNS1 and
CNS222) and non-CNS (228 kb, 28 kb, +6.5 kb) sites
across the Ifng locus that results from T cell activation
and differentiation.
The T-bet-dependent augmentation of promoter-re-
porter expression by CNS222 and CNS234 in transient
transfection analyses (Figure 2) suggested that T-bet
might interact with these sites, either directly or indi-
rectly. To address this, ChIP analysis was performed
to examine the binding of T-bet at sites previously char-
acterized for H4 histone acetylation (Figure 3B). Not sur-
prisingly, we found no substantial interaction of T-bet
with any of the sites examined in Th2 cells. In contrast,
and in agreement with the transient transfection analy-
ses (Figure 2), T-bet-specific interactions were demon-
strated at CNS222 and at the proximal promoter in
both stimulated and resting Th1 cells (Figure 3B). Also
in agreement with the transient transfection analyses,
ChIP analysis identified interaction of T-bet with
CNS234 in both unstimulated and stimulated Th1 cells,
consistent with the presence of a consensus Brachyury
site. Further, T-bet significantly interacted with CNS255
in stimulated Th1 cells, despite no demonstrable effect
of this CNS on T-bet-dependent expression in the tran-
sient transfection assay. While the 228 kb region dem-onstrated the highest degree of histone hyperacetyla-
tion (Figure 3A), T-bet did not interact significantly at
this site. As previously reported (Chang and Aune,
2005; Lee et al., 2004; Shnyreva et al., 2004), we find de-
tectable binding of T-bet at CNS1 in unstimulated and
stimulated Th1 cells, albeit minimal compared to that
found for the other CNSs examined. Taken together,
these data established specific interactions of T-bet
with CNS222, CNS234, and the IfngP in both unstimu-
lated and stimulated Th1 cells, but not Th2 cells. In the
case of CNS222 and the proximal promoter, T-bet
would appear to be poised at these sites prior to T cell
activation, since no significant differences in T-bet-de-
pendent immunoprecipitation were detected in resting
and restimulated cells. In contrast, marked increases
in T-bet interactions were found at both CNS234 and
CNS255 after T cell stimulation.
Development and Characterization of a BAC
Transgenic Model for In Vivo Analyses
of CNS Function
The foregoing results from in vitro promoter-reporter
and the ChIP analyses, coupled with the high concentra-
tion of transcription factor binding sites and degree of
sequence conservation, suggested that CNS222 might
play an important regulatory role in the expression of
the Ifng. To investigate the regulatory properties of this
CNS element in vivo, we developed a BAC transgenic re-
porter system in which the coding sequence of a reporter
was knocked in-frame into the first exon of the Ifng gene
to report Ifng gene expression (Ifng-reporter BAC-In).
Because this approach accurately reports activation of
the transgenic allele without perturbing the endogenous
alleles or producing additional Ifng transcripts, potential
confounding effects of altered IFNg production that
might result from targeting of the endogenous alleles
were obviated. Further, because the BAC-In transgene
reports with fidelity from a single allele, the need to target
both endogenous alleles was avoided, thereby facilitat-
ing future studies to target multiple regulatory regions
in the reporter transgene as well as avoiding compli-
cating breeding strategies that would result from the
necessity of breeding endogenously targeted alleles to
homozygosity.
The Ifng-Thy1.1flCNS-22 BAC-In transgene (hence-
forth abbreviated gBIfl-22 Tg) was constructed by
means of recombineering methodology to target the
coding sequence of the Thy1.1 (CD90.1) gene coupled
to an SV40 polyA site into the first exon of Ifng in the con-
text of a mouse BAC containing 60 kb upstream and 100
kb downstream flanking genomic sequence (Figure 4A).
Thy1.1 (CD90.1) was chosen as a reporter because of its
low immunogenicity and ease of detection in the context
of CD90.2 allotype of the C57BL/6 background. The
Thy1.1-targeted BAC was then retargeted to introduce
loxP sites that flank the CNS222 site. Recombined
BACs containing the Thy1.1 reporter and floxed
CNS222 were confirmed by PCR and sequencing and
were microinjected into fertilized C57BL/6 oocytes.
Founder mice were screened for the presence of the
Thy1.1 reporter by PCR and flow cytometry (data not
shown). Detailed examination of two transgenic founder
lines demonstrated that each of the lines had normal
numbers of CD4+ and CD8+ T cells, had no gross
A Distal CNS Controls Ifng Gene Expression
723Figure 4. Development of the Ifng-Thy1.1flCNS-22 BAC-In Model
(A) A bacterial artificial chromosome (BAC) containing the Ifng gene (gray boxes) with approximately 60 kb of upstream and 100 kb of down-
stream sequence was modified with recombineering. Thy1.1 (diagonal stripes) followed by an SV40 poly A site (black dots) was introduced
just downstream of the Ifng translational start site, replacing the coding sequence of exon 1, and loxP sites (diamonds) flanking the CNS222
(white dots) were added.
(B) Southern blot analyses demonstrating a single copy of the Ifng-Thy1.1flCNS-22 transgene. Genomic DNA from a BAC-In transgenic mouse
and from a C57BL/6 littermate control were digested with BamHI, blotted to nylon membrane, and probed with a fragment of the Ifng gene. The
probe hybridizes to both the 10.4 kb endogenous band and the 7.2 kb transgenic band. Via densitometry, copy number was determined by
comparing the intensity of the BAC-In band versus the endogenous band.abnormalities in the thymic or extrathymic lymphoid tis-
sues (data not shown), and had essentially the same
Thy1.1 reporter expression profile. Southern blot analy-
sis and densitometry established that while reporter
expression was equivalent, one founder possessed
a single copy of the transgene (line 1), whereas another
line (line 2) had integrated in excess of 20 copies of the
transgene (Figure 4B; Figure S3 and data not shown),
indicating that insertion site- and copy number-depen-
dent effects were negligible in these lines. PCR and
pulse field gel electrophoresis (PFGE) Southern analy-
ses determined that the complete BAC transgene was
integrated intact in each of the founder mice genomes
(Figures S4B and S4C). The founder line with a single
copy of the transgene was chosen for further study.
To assess fidelity of Thy1.1 reporter expression in
gBIfl-22 transgenic mice, naive CD4+ T cells were
isolated from mice in which the floxed CNS222 site
had not been deleted and were cultured under Th1 or
Th2 polarizing conditions for analysis of Thy1.1 reporter
and endogenous IFNg expression. There was excellent
activation-, differentiation-, and lineage-specific regula-
tion of reporter expression relative to the endogenous
Ifng genes (Figure 5A and data not shown). Notably,
the frequencies of IFNg+ Th1 cells were comparable be-
tween transgenic and wild-type C57BL/6 (B6) littermates
(50.0% versus 57.1%), as were single-cell levels of en-
dogenous IFNg expression, indicating no perturbation
of endogenous gene expression by the BAC-In trans-
gene. Similarly, comparable frequencies of Th2 cells
derived from transgenic and nontransgenic mice ex-
pressed IL-4, demonstrating that the transgene had no
untoward effects on Th1 or Th2 development. As antic-
ipated from prior reports of allelic utilization of cytokine
genes (Hsieh et al., 2000; Kelly and Locksley, 2000), or
perhaps because of position effect variegation of the
transgenic allele, the fraction of IFNg+ T cells that coex-
pressed Thy1.1 was approximately one-third of the total
of IFNg+ Th1 cells in hemizygous transgenic mice
(14.1% Thy1.1+/IFNg+ versus 50.0% total IFNg+, Fig-
ure 5, and see Figure 6). Importantly, however, essen-
tially all of the cells that expressed the Thy1.1 reporter
also expressed IFNg, validating the model for accurate
identification of IFNg+ CD4+ T cells.Similar results were found for CD8+ effector cells
(CTLs) generated in vitro (Figure 5B). Again, there was
accurate marking of approximately one-third of IFNg+
cells for Thy1.1 (36.6% of total IFNg+ cells). In studies
that have compared reporter transgene and endoge-
nous Ifng gene expression in the context of a challenge
with lymphocytic choriomeningits virus (LCMV) in vivo,
comparable correlation of transgene and endogenous
Ifng gene expression has been observed (data not
shown). Thus, the gBIfl-22 reporter transgene accurately
mirrored expression of the endogenous Ifng alleles in all
effector T cell lineages.
To examine the function of CNS222, gBIfl-22 Tg mice
were bred with mice transgenic for the Cre recombinase
under control of the adenovirus EIIa promoter, which
targets expression to the early mouse embryo (EIIa-
cre) to delete the floxed CNS222 element in the germline
(Lakso et al., 1996). PCR and PFGE Southern blot analy-
ses of founder mice positive for both the gBIfl-22 and
EIIa-cre transgenes confirmed deletion of the CNS222
and integrity of the remaining BAC transgene after re-
combination (Figures S4A–S4C); these mice were then
crossed with WT C57Bl/6 to remove the EIIa-cre trans-
gene. As in the nondeleted BAC-In animals, CNS-deleted
gBIfl-22 mice (referred to as gBIfl-22D) were completely
healthy and had normal immune phenotypes (data not
shown). Both gBIfl-22 and gBIfl-22D mice were then
bred to OT-II TCR transgenic mice so that the function
of the CNS could be assessed in an antigen-specific
system.
Th1 and Th2 cells derived from WT OT-II, gBIfl-22.OT-
II, and gBIfl-22D.OT-II mice were examined for expres-
sion of IFNg, IL-4, and Thy1.1. Consistent with previous
results (Figure 5), comparable frequencies of Th1 cells
from each of the mice were IFNg+ (87.8% versus
74.5% versus 81.4%; Figure 6A). Remarkably, while
approximately half of the IFNg+ cells from the CNS-con-
taining BAC-In transgenic line expressed Thy1.1 (44.6%;
gBIfl-22D.OT-II), only 1.1% of IFNg+ cells from the
CNS222-deleted mice (gBIfl-22D.OT-II) were positive
for Thy1.1. The loss of Thy1.1 expression was so pro-
found that the profiles of the deleted mice appeared
essentially identical to the OT-II controls. In Th2 cells,
the results of CNS222 deletion were similar; the small
Immunity
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(A) CD4+ T cells from a gBIfl-22 transgenic or C57BL/6 control mice were cultured under Th1 or Th2 polarizing conditions. After 5 days, cells were
restimulated with PMA and ionomycin and stained intracellularly with antibodies specific for IFNg, IL-4, and Thy1.1.
(B) Splenocytes and lymph node cells from a littermate control and from gBIfl-22 transgenic mice were cultured with anti-CD3 and IL-12. On day
three, restimulation with PMA and ionomycin followed by intracellular staining for IFNg and Thy1.1 was performed.
The data shown are gated on CD4- (A) or CD8 (B)-positive T cells and the values represent the percent of CD4+ or CD8+ T cells in each quadrant.fraction of Thy1.1 and IFNg double-positive cells found
in the intact BAC-In mice was completely eliminated
in CNS222-deleted animals. Again, no Thy1.1 was
expressed by IL-4-positive cells derived from any of
the mice tested, including those derived from gBIfl-
22D.OT-II animals. Thus, the CNS222 element was re-
quired for Ifng reporter expression by antigen-activated
effector CD4 T cells, and its deletion did not lead to
aberrant activation of the Ifng locus.
Distinct signaling pathways that can activate the Ifng
gene have been identified for Th1 cells: a TCR-depen-
dent pathway and a TCR-independent pathway that is
stimulated by IL-12 and IL-18 (Robinson et al., 1997;
Yang et al., 1999, 2001). To determine whether CNS2
22 is required for TCR-independent Ifng expression,
Th1 and Th2 cells derived from each of the three cohorts
of mice were stimulated with IL-12 plus IL-18, and en-
dogenous Ifng and Thy1.1 expression were assessed
(Figure 6B). Similar frequencies of IFNg-positive T cells
were elicited from OT-II control and both the CNS222
deleted and nondeleted BAC-In animals (57.5% versus
34.5% versus 47.4%, respectively). Th1 cells bearing
the CNS222-containing transgene (gBIfl-22.OT-II) and
activated with IL-12 plus IL-18 had a similar fraction of
IFNg cells that expressed Thy1.1 positive as seen previ-
ously with PMA and ionomycin stimulation. IL-12 plusIL-18-stimulated Th1 cells from CNS222-deleted mice
completely lacked Thy1.1 expression, demonstrating
that the CNS222 was required not only for TCR-depen-
dent, but also for TCR-independent pathways of Ifng re-
porter expression by effector T cells (Figure 6B). Exam-
ination of CD8+ effector cells revealed similar ablation of
Thy1.1 expression in CNS222-deleted animals as that
seen in the CD4+ effector populations (Figure 6C). IFNg
expression by NK cells also appears to be under similar
control of CNS222, as indicated by the fact that the fre-
quency of IFNg producers expressing Thy1.1 was nearly
ablated in the CNS-deleted animals compared to mice
containing the intact transgene (3.2% versus 48.3%)
(Figure S5). The intact CNS222 element was thus re-
quired for expression of the Ifng reporter by each of
the founder line immune cell lineages, irrespective of
the pathway of activation, thereby implicating a critical
role for this element in the regulation of endogenous
IFNg expression.
Discussion
In this study, we report the identification and character-
ization of a conserved, distal cis-regulatory element,
CNS222, that appears essential for expression of the
Ifng gene by both adaptive and innate immune effector
A Distal CNS Controls Ifng Gene Expression
725Figure 6. Deletion of the CNS222 Abolishes Expression of the Ifng Gene
(A and B) Purified CD4+ T cells from WT OT-II (OT-II), gBIfl-22.OT-II (+CNS), or gBIfl-22D.OT-II (2CNS) transgenic mice were cultured with
OVA peptide and APCs under Th1 or Th2 polarizing conditions. After 5 days, CD4 T cells were harvested, restimulated with PMA and ionomycin
(A) or IL-12 and IL-18 (B), and stained intracellularly with antibodies specific for IFNg, IL-4, and Thy1.1.
(C) Splenocytes and lymph nodes cells from WT OT-I (OT-I), gBIfl-22.OT-I (+CNS), or gBIfl-22D.OT-I (2CNS) were cultured for 3 days with
SIINFEKL peptide and IL-12. On day 3, the cells were restimulated with PMA and ionomycin and stained intracellularly for Thy1.1 and IFNg.
Data shown are gated on CD4+ (A and B) or CD8+ (C) lymphocytes and the values represent the percent of CD4+ or CD8+ T cells in each quadrant.cells (Th1 and CTL effectors, and NK cells). CNS222 is
associated with T-bet in resting and activated Th1 cells
and functions as an enhancer for Ifng gene expression.
In contrast to other CNS elements that have been iden-
tified in the Ifng locus in this and other studies (Lee et al.,
2004; Shnyreva et al., 2004), CNS222 resides in a region
of histone hyperacetylation in both Th1 and Th2 cells
and contains a cluster of transcription factor consensus
binding sites important in Th1 and Th2 lineage specifica-
tion, suggesting that it may play roles in both activating
and silencing expression of IFNg in distinct lineages.
These findings, in concert with the observed ablation of
TCR-dependent and -independent Ifng reporter expres-
sion after CNS222 deletion in the Ifng-Thy1.1flCNS-22
BAC-In transgene, suggest that CNS222 might have
global regulatory function for the Ifng locus, although
additional studies will be needed to clarify this.
T-bet is considered a master regulator of Th1 dif-
ferentiation and has been proposed to act both as an ini-
tiator of chromatin remodeling at the Ifng locus and as
an acute transcriptional enhancer of Ifng expression
in CD4 T cells. Previous studies identified two CNSs
in the Ifng locus, located at 5 kb upstream (CNS1 orCNS25) and 17 kb downstream (CNS2 or CNS+17),
that can function as T-bet-dependent enhancers in vitro
and are associated with Th1 cell-specific expression of
Ifng (Lee et al., 2004; Shnyreva et al., 2004). The demon-
stration herein that CNS222 and CNS234, and to a
lesser extent, CNS255, behave similarly is compatible
with models in which T-bet may interact with multiple
cis-elements in the Ifng locus to induce Th1-specific ex-
pression (Chang and Aune, 2005). To date, however,
functional mapping of T-bet-responsive cis-elements
has been limited to transient transfection assays and
has not been examined in the context of an intact Ifng lo-
cus in vivo. Our findings that CNS222 resides in a region
of permissive chromatin structure, that T-bet binds di-
rectly to CNS222 and acts as a potent T-bet-dependent
enhancer in vitro, and that deletion of the CNS222 in the
context of the BAC-In transgene suggests its involve-
ment in regulating Ifng expression in vivo identify this el-
ement as an important regulatory node for T-bet actions
in the context of Th1 development, thereby providing a
basis for future studies to define mechanisms by which
T-bet interacts with other factors in CNS222 to regulate
the Ifng locus. In this regard, it is of interest that deletion
Immunity
726of CNS222 blocked Ifng reporter expression in effector
CD8+ T cells (CTLs) comparably to that for Th1 cells. Ifng
expression in CD8 T cells is retained in T-bet-deficient
(Tbx212/2) mice due to coexpression in this lineage of
the gene encoding the T-bet paralog Eomesodermin
(Eomes) (Pearce et al., 2003). Because Eomes2/2 mice
die in utero, it has been difficult to determine whether
Eomes and T-bet have redundant or cooperative func-
tions for expression of Ifng by CD8+ T cells (Pearce
et al., 2003). However, our data indicate that, regardless
of the mechanism by which Eomes contributes to Ifng
expression in the CD8 lineage, this is dependent on in-
teractions with CNS222. A similar deficiency of reporter
expression by NK cells suggests that mechanisms
controlling Ifng expression require an intact CNS222,
irrespective of hematopoietic lineage or transcription
factors involved.
In view of the profound effects of CNS222 deletion on
Ifng reporter expression by multiple lineages, the clus-
tering of a Tbx consensus binding sequence with bind-
ing sequences for STAT, GATA, interferon regulatory
factor (IRF), NF-kB, and Ikaros factors is compelling.
The loss of IL-12 plus IL-18-induced reporter expression
by Th1 cells in Ifng-Thy1.1flCNS-22D transgenic mice is
consistent with cooperative interactions of STAT4 and
NF-kB at CNS222 (Berenson et al., 2004), although indi-
rect mechanisms cannot be excluded. NF-kB, GATA,
IRF, and Ikaros sites have been identified in a conserved
Rag gene enhancer, Erag, that functions in the T and B
lymphocyte lineages (Hsu et al., 2003; Kubo et al.,
1997). Similarly, STAT6, GATA, IRF, and Ikaros sites
were found in a region of the 30 untranslated region of
Il4 that functions as a silencer (Kubo et al., 1997). Since
CNS222 shares these composite sites with a functional
T-box site, the potential for these factors to both posi-
tively and negatively regulate T-bet-induced Ifng ex-
pression is entirely feasible. It has been demonstrated
that a phosphorylated form of T-bet interacts with
GATA3 to repress Th2 lineage development, possibly
by sequestering GATA3 away from its Th2 cytokine
binding targets (Hwang et al., 2005b). The juxtaposition
of GATA3 and T-box sites in CNS222 suggests a
platform for the interaction of these two factors in the
Ifng locus, and, since the CNS222 element is in an
‘‘open’’ configuration in Th2 cells, this provides a mech-
anism by which GATA3 might repress Ifng expression
during Th2 development. Although we did not find dere-
pression of the Ifng locus after CNS222 deletion, this is
likely due to loss of critical positive regulatory elements
in this site.
T-bet has also been shown to form heterodimers with
RelA NF-kB, thereby interfering with RelA binding of the
IL-2 promoter and repressing IL-2 production (Hwang
et al., 2005a). The T-bet and NF-kB sites in CNS222
are highly conserved in mammals and birds, and though
spaced a greater distance than in the IL-2 promoter, di-
merization of these two factors at CNS222 is possible.
c-Rel, an NF-kB family member, appears to be required
for chromatin remodeling of the IL-2 locus, raising the
possibility that T-bet physically interacts cooperatively
with NF-kB at CNS222 to effect changes in chromatin
accessibility. In this regard, it is notable that Chang
and Aune (2005) found comparable hyperacetylation of
histones in the vicinity of CNS222 in both wild-typeand T-bet-deficient (Tbx212/2) mice, suggesting that
T-bet is not required for histone modifications at this
site. In contrast, it was found that hyperacetylation of
this region was lost in Stat42/2 mice, consistent with
a role for STAT4 in regulating chromatin remodeling in
this region of the Ifng locus. Unfortunately, the specific
sites analyzed by ChIP were not reported in that study,
and therefore a more precise mapping of this region in
the context of Th1 and Th2 lineage-specific factors will
be needed, for which the Ifng-Thy1.1flCNS-22 model
should be ideal.
Of the Ifng CNSs and non-CNSs that have been ana-
lyzed in this and prior studies, only CNS222 appears
to be associated with substantial histone modification
in Th2 cells and, to a somewhat lesser extent, in naive
CD4+ cells (Shnyreva et al., 2004). Since Ifng can be ex-
pressed immediately from activated cells of the innate
immune system and naive CD4+ cells have the potential
to rapidly express at least low levels of IFNg upon acti-
vation (Grogan et al., 2001), it may be that accessibility
of CNS222 is the default chromatin conformation in
hematopoeitic cells and that transcription factors in-
duced during Th1 or Th2 lineage differentiation either
potentiate or silence Ifng expression, respectively. In
this regard, it is of interest that Spilianakis et al. recently
demonstrated interchromosomal interactions between
regulatory regions in the Th2 cytokine locus interact
and the Ifng locus, particularly in naive T cells (Spiliana-
kis and Flavell, 2004). Given the permissive chromatin
structure of CNS222 in naive, Th1, and Th2 cells, it is
tempting to speculate that CNS222 is involved in the in-
teractions of the Ifng loci on chromosome 10 with the
Th2 cytokine loci on chromosome 11 and may be a focus
for coordination of physical interactions between the
loci, although this will require further studies. Another in-
triguing possibility is that the CNS222 is either the
source or the target of regulatory RNAs. While there is
limited information on their role in gene expression, in-
tergenic transcripts have been identified from regulatory
regions in the b-globin, IL-4, and IL-10 locus (Jones and
Flavell, 2005). It will be interesting to determine whether
similar transcripts exist in the IFNg locus, and if so, their
function. Also, it has been recently shown that defi-
ciency in Dicer, an enzyme required for generating
siRNAs and miRNAs, results in aberrant IFNg expression
in Th2 cells (Muljo et al., 2005). Given the accessibility
of the CNS222 in Th2 cells, these data suggest another
potential mechanism for the silencing of IFNg in Th2
cells.
In summary, we have confirmed the utility of bioinfor-
matics-based methods to identify distal cis-regulatory
regions in the Ifng locus and have developed a BAC
transgenic model system with which to study function
of these elements in vivo. While it is possible that the
regulation of expression of the Thy1.1 reporter may dif-
fer from Ifng due to increased message stability con-
ferred by the SV40 polyA, we found no untoward effects,
and the BAC transgenic reporter system proved ex-
tremely useful in that it marked IFNg-positive cells with
high fidelity, allowing investigation of the function of
CNS222 without perturbing endogenous loci. Condi-
tional deletion of CNS222 resulted in loss of transgenic
reporter expression in effector CD4+ and CD8+ T cells,
irrespective of activation through the TCR-dependent
A Distal CNS Controls Ifng Gene Expression
727or TCR-independent, as well as NK cells, establishing
a central role for this element in Ifng gene expression.
Given that the efficiency with the BAC-In transgene
can be manipulated by recombineering techniques,
fine-mapping of the CNS222 region is possible and
will permit more detailed study of the factors that inter-
act at CNS222, or other CNSs, to drive lineage-specific
expression of Ifng.
Experimental Procedures
Mice and Cell Lines
The EL-4 cell line (Szabo et al., 1993) was maintained in Iscove’s
supplemented with 10% fetal calf serum, 20 mM glutamine, 10 mM
HEPES, penicillin (1000 U/ml), and streptomycin (1000 U/ml). 3T3 fi-
broblasts were maintained in DMEM with 10% fetal calf serum, pen-
icillin (1000 U/ml), and streptomycin (1000 U/ml). The following mice
were purchased from the Jackson Laboratories and/or were bred at
the University of Alabama at Birmingham: BALB/cByJ (BALB/c),
C57BL/6J, B6.FVB-Tg(EIIa-cre)C5379Lmgd/J, and TCR transgenics
DO11.10, OT-I, and OT-II. All animal experimentation was conducted
in accordance with institutional guidelines.
To generate the Ifng-Thy1.1flCNS-22 BAC-In transgenic mouse
line, recombineering was used to introduce the Thy1.1 coding se-
quence linked to SV-40 polyA site into the first exon of Ifng and
loxP sites flanking the CNS222 in BAC clone 348O11RP-24 (CHORI,
Oakland, CA). In brief, Thy1.1 was cloned from cDNA reverse tran-
scribed from RNA prepared from BALB/c Thy1.1 lymph node cells.
SV40 poly A sequence was cloned 30 of the Thy1.1 gene. PCR with
the following oligos (50-CATGCAAGTATTAACATGCAATTGTCTAC
ACACACACACACACACGTGAAATTTGATGTTTGCTATAAGAAGTTC
CTATACTTTCTAG-30 and reverse oligo 50-GAAAATTAGACACCTA
ATTTGCTAATTAGAATCATAGATCATAACTCATTATGATTTTTTAGG
ATAACTTCGTATAGCATACAT-30) was used to amplify a fragment
containing w75 base pairs of sequence upstream of the Ifng gene
including the ATG directly juxtaposed and in-frame with the second
codon of the Thy1.1-SV40 poly A construct and w75 base pairs of
Ifng intron 1 directly following the SV40 poly A. This fragment was
introduced into the DY380 bacterial strain containing l-prophage
recombination genes exo, bet, and gam under the control of a tem-
perature-sensitive repressor cI857 along with BAC 348O11RP-24
and recombination was induced by a brief heat shock (Lee et al.,
2001). Recombined BACs containing the Thy1.1-SV40 construct
were identified by colony hybridization and confirmed by DNA se-
quencing. To facilitate screening of successfully recombined
BACs with loxP sites flanking the CNS222, a kanamycin cassette
flanked by frt sites (allowing for excision with flp recombinase)
was juxtaposed next to the CNS222 in an intermediate construct.
LoxP sites flanking the CNS222 were then introduced into this inter-
mediate. The floxed CNS222/frt-flanked kanamycin construct was
then flanked by arms with 60 base pairs of homology to the targeted
region of the CNS222 by PCR with forward oligo 50-CATGCAAG
TATTAACATGCAATTGTCTACACACACACACACACACGTGAAATTT
GATGTTTGCTATAAGAAGTTCCTATACTTTCTAG-30 and reverse
oligo 50-GAAAATTAGACACCTAATTTGCTAATTAGAATCATAGATC
ATAACTCATTATGATTTTTTAGGATAACTTCGTATAGCATACAT-30,
and the Thy1.1-SV40 containing BAC was subjected to further re-
combination with this fragment. Recombined kanamycin-resistant
BACs were subjected to sequencing to validate the presence of
loxP sites flanking CNS222 and then were transformed into DH10B
cells previously transformed with a flp recombinase expression
vector (Gene Bridges, Dresden, Germany) to remove the kanamycin
cassette completing the construction of the Ifng-Thy1.1flCNS-22
BAC-In transgene. The transgene was microinjected into fertilized
C57BL/6 oocytes, and resulting pups were screened by PCR for
presence of the Thy1.1 reporter and the loxP flanked CNS222.
Ifng-Thy1.1flCNS222 BAC-In transgenic mice were then bred to
OT-I and OT-II mice, generating progeny hemizygous for both trans-
genes. To delete CNS222, the Ifng-Thy1.1flCNS222 mice were bred
to B6.FVB-Tg(EIIa-cre)C5379Lmgd/J and then bred to WT B6 or OT-I
and OT-II mice. Progeny in which the EIIa-cre transgene had been
eliminated by subsequent breedings were used in experiments.CD4+ T Cell Isolation, Th1 and Th2 Generation,
and CD8-Enriched Cultures
Spleens and lymph nodes were isolated from the indicated strains
of mice, and single-cell suspensions were prepared by mechanical
disruption. CD4+ T cells were isolated by positive sorting with anti-
CD4 magnetic beads (Invitrogen; Carlsbad, CA) according to the
manufacturer’s instructions. Irradiated (3000 rads) splenic feeder
cells were used as APCs and were cultured with CD4+ T cells at
a ratio of 5:1. Non-TCR transgenic CD4+ T cells were activated
with 2.5 mg/ml anti-CD3 (clone 145-11), whereas CD4+ T cells from
DO11.10 or OT-II mice were cultured with 5 mg/ml OVA peptide
323-339. The addition of 50 U/ml IL-12 (R&D Systems, Minneapolis,
MN) and 10 mg/ml anti-IL-4 (11B11) was used to generate cells with
a Th1 phenotype, while 1000 U/ml IL-4 (R&D Systems) with 10 mg/ml
anti-IL-12 (C17.8) and 10 mg/ml anti-IFNg (XMG1.2) was used to
differentiate Th2 cells. To enrich for the generation of CD8+ T cells,
red cell-lysed splenocytes were cultured for 3 days with lymph
node cells at a concentration of 4 3 106/ml with 50 U/ml IL-12 and
either 2.5 mg/ml anti-CD3 (non-TCR transgenics).
Generation of CNS Promoter-Reporter Constructs,
EL-4 Transfection, and Luciferase Assay
The 22363, 2586, and 2468 mouse promoter fragments of the Ifng
proximal promoter were previously described (Cho et al., 2003) and
were cloned into the pGL3 basic luciferase vector (Promega; Madi-
son, WI). KpnI and Sac I sites were introduced flanking CNS222,
CNS234, and CNS255, facilitating the juxtaposition of each CNS
upstream of proximal promoter fragments in pGL3. Clones for
each construct were isolated and sequenced to prove authenticity.
2.5 3 106 EL-4 cells was electroporated at 280 V and 960 mF with
20 mg of the indicated promoter/reporter constructs and 0.2 mg
pRL-TK with and without 2.5 mg of T-bet expression plasmid (Cho
et al., 2003). Transfected cells were rested overnight and stimulated
the following day for 5 hr with 50 ng/ml PMA (Sigma-Aldrich;
St. Louis, MO) and 750 ng/ml ionomycin (Calbiochem; San Diego,
CA). After stimulation, the Dual Luciferase Assay (Promega) was
performed by lysing the cells in Passive Lysis Buffer and reading
the relative light units of one-fifth the lysate with both the firefly
substrate and the renilla substrate with a Turner Systems TD 20/20
luminometer (Promega). Each transfection was performed in tripli-
cate and data are from a minimum of five independent experiments.
Chromatin Immunoprecipitation
Chromatin was prepared from 1 3 106 3T3 or 1 3 107 naive CD4+ T
cells and 5 day polarized resting or restimulated (5 hr with 50 ng/ml
PMA and 750 ng/ml ionomycin) Th1 and Th2 cells from DO11.10
TCR transgenic mice for each reaction with the Acetyl-Histone H4
Immunoprecipitation (ChIP) Assay Kit from Upstate Cell Signaling
Solutions (Charlottesville, VA) according to the manufacturer’s in-
structions. Immunoprecipitations were performed with either the
kit’s acetylated Histone H4 antibody, a mono/di/trimethyl-Histone
H3 K4 antibody (Upstate Cell Signaling Solutions), or a T-bet-specific
rabbit polyclonal antibody prepared by Brookwood Biomedical (Bir-
mingham, AL). Immunoprecipitated DNA released from crosslinked
proteins was used in real-time PCR reactions performed for 40 cycles
with 1.253 Platinum Quantitative PCR mix-UDG (Invitrogen) on a
BioRad iQsystem(Hercules,CA). PCRreactions for regions of interest
(ROI) in the Ifng locus and the HS VA in the Il4 locus from acetyl-
Histone H4-immunoprecipitated samples were normalized to the
amplification of the 16S ribosomal protein promoter, while T-bet reac-
tions were normalized to input DNA. All real-time PCR primers and
probes are included in the Supplemental Data. The relative histone
H4 acetylation and T-bet binding values were calculated with the
DDCt method as follows: [3T3 (ROI Ct 2 16S ribosomal promoter
Ct)]2 [T cell (ROI Ct2 16S ribosomal promoter Ct)] = n with 2n repre-
senting the relative values. Relative values in Th1 and Th2 cells were
compared using two-way analysis of variance (ANOVA) with the T
helper cell subset (1 or 2) or the activation status (resting or restimu-
lated) as the two factors in theANOVA. Data aregiven asmean6SEM.
Intracellular Cytokine Staining
Th1 and Th2 cells cultured for 5 days or CD8-enriched spleen/LN
cultures grown for 3 days were collected and were left unstimulated
or were stimulated for 5 hr with 50 ng/ml PMA and 750 ng/ml
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728ionomycin in the presence of Golgistop (BD Pharmingen, San Diego,
CA) at the recommended concentration. Standard intracellular cyto-
kine staining was performed as described (Murali-Krishna et al.,
1998). Cells were first stained extracellularly with phycoerythrin-
conjugated anti-CD4 (RM4-5), then were fixed, permeabilized with
Cytofix/Cytoperm (BD Pharmingen), and stained intracellularly
with allophycocyanin-conjugated anti-IFNg (XMG1.2) or anti-IL-4
(11B11), and fluorescein isothiocyanate-conjugated anti-CD90.1
(OX-7). Samples were acquired on a FACSCalibur (BD, San Jose,
CA), and data were analyzed with CellQuestPro software (BD).
Statistical Analyses
Statistical significance was calculated by unpaired Student’s t test,
Mann-Whitney U test, or ANOVA as appropriate. All p values%0.05
are considered significant, unless specifically indicated in the text.
Supplemental Data
Supplemental Data include five figures and one table and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/5/717/DC1/.
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